Letter RDF
pages:- Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply
- Opioid therapy and sleep apnea REPLY
- Palliative Care And Hospice
- Parenteral versus enteral nutrition in the critically ill patient: a re-analysis of a flawed meta-analysis
- Paroxetine Use Should Be Avoided During Pregnancy
- Participation of Medical Students in Discharge Tasks: A Needs Assessment
- Pathogenic Colonization: Defining the Role of Staphylococcus aureus in Atopic Dermatitis
- Pediatric Topical Steroid Withdrawal Syndrome: What Is Known, What Is Unknown
- Pemphigus vulgaris flare in a patient treated with nivolumab
- Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis
- Placental phenotype in non-immune hydrops fetalis with negative standard workup
- Pocket guide: biologics in upper and lower airways in adults
- Pragmatic Clinical Decision Support Trial of Pre-checked Default Orders: Monitoring Safety and Adverse Clinical Outcomes
- Pregnancy outcomes in patients with suspected SARS-CoV-2 infection before delivery
- Prevalence of pathergy after surgical procedures in patients with history of pyoderma gangrenosum
- Primary Cutaneous Extraskeletal Osteosarcoma of the Temple Treated by Mohs Micrographic Surgery
- Procalcitonin is an essential biomarker for hydrocortisone, ascorbic acid, and thiamine (HAT) therapy in patients with sepsis
- Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258-264
- Prolonged Noninvasive Respiratory Support Before Intubation Leads to Increased Duration of ECMO: More Evidence That Less Is More
- Protein Profiling in Urine for the Diagnosis of Bladder Cancer
- Pseudobulbar palsy and affect in a case of progressive multifocal leukoencephalopathy
- Quantification of mitochondrial abundance REPLY
- Racial/ethnic differences in biologic treatment patterns among patients with psoriasis: A prospective analysis of patients in the CorEvitas Psoriasis Registry
- Randomized controlled trials to assess optimal aspirin dose are warranted
- Re-thinking resuscitation goals: an alternative point of view!
- Re: 'Post-COVID-19 chronic symptoms' by Davido et al.
- Re: Atkuru et al.: Trends in racial diversity among United States ophthalmology residents (Ophthalmology. 2022;129:957-959) REPLY
- RE: Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study
- Readability of patient materials on atopic dermatitis: The possible role of artificial intelligence
- Recalcitrant herpetic scrotal ulcer as a manifestation of immune reconstitution inflammatory syndrome